Zynex reports preliminary first quarter 2022 results and provides business update

Englewood, colo. , april 8, 2022 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for first quarter 2022, affirming guidance for revenue, ebitda and order growth.
ZYXI Ratings Summary
ZYXI Quant Ranking